DUBLIN, Ireland, July 10, 2017 (GLOBE NEWSWIRE) — Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that its second-quarter 2017 financial results will be released on Monday, Aug. 7, 2017. Following the announcement, Horizon’s management will host a live conference call and webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.
The live webcast and a replay may be accessed at http://ir.horizon-pharma.com. Please connect to the Company’s website at least 15 minutes before the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 45942068. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 45942068.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
CONTACT: Contacts: Investors: Tina Ventura Senior Vice President, Investor Relations email@example.com Ruth Venning Executive Director, Investor Relations firstname.lastname@example.org U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer email@example.com Ireland Media: Ray Gordon Gordon MRM firstname.lastname@example.org